Skip to main content
FEMY
NASDAQ Life Sciences

Femasys Reports $2.29M Revenue, $(0.47) Net Loss Per Share in 2025 10-K

Tom Rudovsky · Reported by Wiseek News
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.425
Mkt Cap
$25.003M
52W Low
$0.307
52W High
$1.34
52W Position info
39% above low
Off High info
68% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

FEMY sits 39% above its 52-week low of $0.307.

Summary

Femasys reported its 2025 fiscal year results from its 10-K filing, showing revenue of $2.29 million, a 40.8% increase year-over-year, driven by commercialization of FemBloc and FemaSeed. However, the company posted a significant net loss per share of $(0.47). This follows a Reuters report earlier today that highlighted a 41% sales surge, but the 10-K provides the official figures and, critically, the substantial net loss per share. This loss is particularly impactful given the company's current stock price of $0.425, indicating ongoing operational losses and potential financial strain for the small-cap company. Investors will closely monitor Femasys's ability to reduce these losses and achieve profitability amidst its commercialization efforts and recent corporate governance actions, including a proposed reverse stock split.

At the time of this announcement, FEMY was trading at $0.43 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $25M. The 52-week trading range was $0.31 to $1.34. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

FEMY - Latest Insights

FEMY
Nov 13, 2026, 4:54 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1.44
Real-time Price: $1.26 info
Change: -$0.180 (-12%) info
Market Cap: $9.695M info
FEMY
Sep 29, 2026, 7:02 AM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $2.38
Real-time Price: $1.26 info
Change: -$1.12 (-47%) info
Market Cap: $9.695M info
FEMY
Sep 03, 2026, 5:06 PM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $3.04
Real-time Price: $1.26 info
Change: -$1.78 (-59%) info
Market Cap: $9.695M info
FEMY
Aug 26, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.88
Real-time Price: $1.26 info
Change: -$1.62 (-56%) info
Market Cap: $9.695M info
FEMY
Aug 19, 2026, 9:02 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $2.15
Real-time Price: $1.26 info
Change: -$0.890 (-41%) info
Market Cap: $9.695M info